IhabGirgisMD
Cardiology • Neptune, NJAdult Congenital Heart Disease, Cardiac Electrophysiology
Physician
Dr. Girgis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1820 State Route 33
Ste 4B
Neptune, NJ 07753Phone+1 732-776-8500Fax+1 732-988-2347
Education & Training
University of Miami/Jackson Health SystemFellowship, Cardiovascular Disease, 1993 - 1997
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1990 - 1993- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Surgery, 1988 - 1990
Stony Brook University Health Sciences Center School of MedicineClass of 1988
Certifications & Licensure
NJ State Medical License 1997 - 2025
FL State Medical License 1993 - 2008
NY State Medical License 1989 - 1998- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Electrophysiology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012
- Fellow (FACP) American College of Physicians, 2003
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.C Michael Gibson, Gerald Chi, Danielle Duffy, M Cecilia Bahit, Harvey White
Journal of the American College of Cardiology. 2024-11-26 - 26 citationsFirst-in-human study of deucravacitinib: A selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2.Ian M Catlett, Urvi Aras, Lars Hansen, Yali Liu, Di Bei
Clinical and Translational Science. 2023-01-01 - 10 citationsLack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.Anjaneya Chimalakonda, Shalabh Singhal, Raymond Darbenzio, Randy Dockens, David Marchisin
Clinical Pharmacology in Drug Development. 2022-04-01
Professional Memberships
- Fellow
- Member
Other Languages
- Arabic, Navajo
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
